Achieve Life Sciences offers a compelling risk/reward profile with its promising smoking cessation therapy, cytisinicline.

Bristol Myers Squibb partners with BioNTech in a $11.1B deal to develop BNT327, a promising cancer immunotherapy. Read more ...

Trailhead Biosystems Inc. has named a new chief executive officer as the current CEO — who has served in the position since the biotechnology company was founded in 2015— steps down from the role. The ...

By connecting capital to capability, they help biotech teams avoid costly missteps, bridge investor expectations, and stay focused on the science that sets them apart. “We don’t just help companies ...

Among the largest underlying components of IWD, in trading today Johnson & Johnson (Symbol: JNJ) is up about 0.1%, Procter & Gamble Company (Symbol: PG) is up about 0.1%, and Thermo Fisher ...

Biotechnology company Regeneron Pharmaceuticals is buying 23andMe for $256 million, two months after the genetic testing company filed for Chapter 11 bankruptcy protection. In March, 23andMe said ...

Regeneron Pharmaceuticals is purchasing genetics and biotechnology company 23andMe and has vowed to protect customer data while continuing genome testing services. Regeneron announced the purchase ...

BBiotechnology company Regeneron Pharmaceuticals is buying 23andMe for $256 million, two months after the genetic testing company filed for Chapter 11 bankruptcy protection. In March 23andMe said ...

security and ethical use” of the personal DNA data from about 15 million people in a $256 million deal to acquire assets of bankrupt 23andMe Holding Co. A biotechnology company based in ...